Recent advances on the roles of LncRNAs in cardiovascular disease

J Cell Mol Med. 2020 Nov;24(21):12246-12257. doi: 10.1111/jcmm.15880. Epub 2020 Sep 24.

Abstract

Cardiovascular diseases are a main cause of mortality whose prevalence continues to increase worldwide. Long non-coding RNAs (lncRNAs) regulate a variety of biological processes by modifying and regulating transcription of coding genes, directly binding to proteins and even coding proteins themselves. LncRNAs play key roles in the occurrence and development of myocardial infarction, heart failure, myocardial hypertrophy, arrhythmias and other pathological processes that significantly affect the prognosis and survival of patients with cardiovascular diseases. We here review the latest research on lncRNAs in cardiovascular diseases as a basis to formulate future research on prevention and treatment of cardiovascular diseases.

Keywords: Long Non-coding RNA; biological function; cardiovascular diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Apoptosis
  • Arrhythmias, Cardiac / metabolism
  • Atherosclerosis / metabolism
  • Autophagy
  • Biomarkers / metabolism
  • Cardiology / trends
  • Cardiomyopathy, Dilated / metabolism
  • Cardiovascular Diseases / genetics*
  • Cardiovascular Diseases / pathology
  • Cell Proliferation
  • Heart Failure
  • Histones / metabolism
  • Humans
  • Inflammation
  • Lipid Metabolism
  • Methylation
  • Myocardial Infarction / metabolism
  • Prognosis
  • Protein Binding
  • RNA, Long Noncoding / genetics*
  • RNA, Long Noncoding / physiology*
  • Signal Transduction
  • Treatment Outcome

Substances

  • Biomarkers
  • Histones
  • RNA, Long Noncoding